Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT (Unaudited)

v3.19.2
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)
Series A Preferred Stock
Series B Preferred Stock
Common Stock
Common Stock To Be Issued
Additional Paid-in Capital
Deferred Stock Compensation
Retained Deficit
Total
Beginning balance, shares at Dec. 31, 2017 61,539,334 102,564        
Beginning balance, amount at Dec. 31, 2017 $ 6,153 $ 10 $ 331,227 $ (25,000) $ (1,787,012) $ (1,474,623)
Stock based compensation, shares 224,072 266,401        
Stock based compensation, amount $ 23 $ 27 25,640 25,000 50,690
Stock issued from common stock to be issued, shares (102,564)        
Stock issued from common stock to be issued, amount $ (10) 10
Reclassification of derivative liabilities upon payment of convertible debt 61,044 61,044
Net loss (697,945) (697,945)
Ending balance, shares at Mar. 31, 2018 61,763,406 266,401        
Ending balance, amount at Mar. 31, 2018 $ 6,176 $ 27 417,921 (2,484,957) (2,060,834)
Beginning balance, shares at Dec. 31, 2017 61,539,334 102,564        
Beginning balance, amount at Dec. 31, 2017 $ 6,153 $ 10 331,227 (25,000) (1,787,012) (1,474,623)
Common stock to be issued for settlement of accounts payable, amount              
Net loss               (2,550,969)
Ending balance, shares at Jun. 30, 2018 9,510,000 900,000 48,956,945 814,020        
Ending balance, amount at Jun. 30, 2018 $ 951 $ 90 $ 4,896 $ 81 1,501,129 (4,337,982) (2,830,837)
Beginning balance, shares at Mar. 31, 2018 61,763,406 266,401        
Beginning balance, amount at Mar. 31, 2018 $ 6,176 $ 27 417,921 (2,484,957) (2,060,834)
Stock based compensation, shares 547,619        
Stock based compensation, amount $ 55 13,495 13,550
Issuance of Series B preferred stock, shares 900,000        
Issuance of Series B preferred stock, amount $ 90 817,510 817,600
Common stock issued or to be issued for convertible notes, shares 6,213,539        
Common stock issued or to be issued for convertible notes, amount $ 621 68,749 69,370
Common stock shares cancelled in exchange for Series A preferred stock, shares 9,510,000 (19,020,000)        
Common stock shares cancelled in exchange for Series A preferred stock, amount $ 951 $ (1,902) 951
Reclassification of derivative liabilities upon payment of convertible debt 182,502 182,502
Net loss (1,853,025) (1,853,025)
Ending balance, shares at Jun. 30, 2018 9,510,000 900,000 48,956,945 814,020        
Ending balance, amount at Jun. 30, 2018 $ 951 $ 90 $ 4,896 $ 81 1,501,129 (4,337,982) (2,830,837)
Beginning balance, shares at Dec. 31, 2018 900,000 120,425,344 6,373,848        
Beginning balance, amount at Dec. 31, 2018 $ 90 $ 12,042 $ 637 4,836,556 (235,694) (6,372,129) (1,758,498)
Stock based compensation, shares 870,826 113,637        
Stock based compensation, amount $ 87 $ 11 26,485 97,917 124,499
Stock issued from common stock to be issued, shares 3,550,893 (3,550,893)        
Stock issued from common stock to be issued, amount $ 355 $ (355)
Common stock issued for convertible notes and accrued interest, shares 24,741,320        
Common stock issued for convertible notes and accrued interest, amount $ 2,474 282,792 285,266
Common stock to be issued for settlement of accounts payable, shares 625,000        
Common stock to be issued for settlement of accounts payable, amount $ 63 40,563 40,624
Reclassification of derivative liabilities upon payment of convertible debt 580,908 580,908
Net loss (2,003,038) (2,003,038)
Ending balance, shares at Mar. 31, 2019 900,000 149,588,383 3,561,592        
Ending balance, amount at Mar. 31, 2019 $ 90 $ 14,958 $ 356 5,767,304 (137,777) (8,375,167) (2,730,236)
Beginning balance, shares at Dec. 31, 2018 900,000 120,425,344 6,373,848        
Beginning balance, amount at Dec. 31, 2018 $ 90 $ 12,042 $ 637 4,836,556 (235,694) (6,372,129) (1,758,498)
Common stock to be issued for settlement of accounts payable, amount               389,738
Net loss               (3,508,449)
Ending balance, shares at Jun. 30, 2019 900,000 161,826,468 2,881,316        
Ending balance, amount at Jun. 30, 2019 $ 90 $ 16,182 $ 288 6,397,967 (242,402) (9,880,578) (3,708,453)
Beginning balance, shares at Mar. 31, 2019 900,000 149,588,383 3,561,592        
Beginning balance, amount at Mar. 31, 2019 $ 90 $ 14,958 $ 356 5,767,304 (137,777) (8,375,167) (2,730,236)
Stock based compensation, shares 4,780,303 355,008        
Stock based compensation, amount $ 478 $ 36 337,902 (270,500) 67,915
Amortization of deferred stock compensation 165,875 165,875
Stock issued from common stock to be issued, shares 410,284 (410,284)        
Stock issued from common stock to be issued, amount $ 41 $ (41)
Common stock issued for settlement of accounts payable, shares 625,000 (625,000)        
Common stock issued for settlement of accounts payable, amount $ 63 $ (63)
Common stock issued for convertible notes and accrued interest, shares 6,422,498        
Common stock issued for convertible notes and accrued interest, amount $ 642 135,557 136,199
Reclassification of derivative liabilities upon payment of convertible debt 157,204 157,204
Net loss (1,505,411) (1,505,411)
Ending balance, shares at Jun. 30, 2019 900,000 161,826,468 2,881,316        
Ending balance, amount at Jun. 30, 2019 $ 90 $ 16,182 $ 288 $ 6,397,967 $ (242,402) $ (9,880,578) $ (3,708,453)